NOS3 and atherosclerosis: When balancing HT risks and benefits in early postmenopausal women with CV risk factors such as diabetes and hypertension, ESR1 Pvull, NOS3 G894T and T-786C polymorphism analysis may be considered in relation to endothelial-mediated benefits, fundamental in atherosclerosis progression process.